Ausgabe 11/2012
Inhalt (25 Artikel)
miRNAs can increase the efficiency of ex vivo platelet generation
Stephan Emmrich, Kerstin Henke, Jan Hegermann, Matthias Ochs, Dirk Reinhardt, Jan-Henning Klusmann
Platelet activation and platelet–leukocyte interaction in β-thalassemia/hemoglobin E patients with marked nucleated erythrocytosis
Rassamon Keawvichit, Ladawan Khowawisetsut, Porntip Chaichompoo, Korakot Polsrila, Suchana Sukklad, Kasama Sukapirom, Archrob Khuhapinant, Suthat Fucharoen, Kovit Pattanapanyasat
Molecular mechanisms of a novel β-thalassaemia mutation due to the duplication of tetranucleotide ‘AGCT’ at the junction IVS-II/exon 3
Gennaro Musollino, Gabriella Mastrolonardo, Romeo Prezioso, Leonilde Pagano, Paola Primignani, Clementina Carestia, Giuseppina Lacerra
FLT3 and NPM1 mutations in a cohort of AML patients and detection of a novel mutation in tyrosine kinase domain of FLT3 gene from Western India
Kanjaksha Ghosh, Suchitra Swaminathan, Manisha Madkaikar, Maya Gupta, Lily Kerketta, Baburao Vundinti
Activating CBL mutations are associated with a distinct MDS/MPN phenotype
Juliana Schwaab, Thomas Ernst, Philipp Erben, Jenny Rinke, Susanne Schnittger, Philipp Ströbel, Georgia Metzgeroth, Max Mossner, Torsten Haferlach, Nicholas C. P. Cross, Andreas Hochhaus, Wolf-Karsten Hofmann, Andreas Reiter
Treatment of gastrointestinal diffuse large B cell lymphoma in China: a 10-year retrospective study of 114 cases
Xiaoyang Li, Weina Shen, Junning Cao, Jianmin Wang, Fangyuan Chen, Chun Wang, Shanhua Zou, Boyong Shen, Ren Zhao, Junmin Li, Zhixiang Shen
The comparison between CHOP and R-CHOP in primary gastric diffuse large B cell lymphoma
Byeong Seok Sohn, Sun-Mok Kim, Dok Hyun Yoon, Shin Kim, Dae Ho Lee, Jin-Ho Kim, Sang-Wook Lee, Jooryung Huh, Cheolwon Suh
Value of surveillance computed tomography in the follow-up of diffuse large B-cell and follicular lymphomas
Tung-Liang Lin, Ming-Chung Kuo, Lee-Yung Shih, Po Dunn, Po-Nan Wang, Jin-Hou Wu, Tzung-Chih Tang, Hung Chang, Yu-Shin Hung, Shu-Chen Lu
Prognostic relevance of pretreatment quality of life in diffuse large B-cell lymphoma patients treated with rituximab-CHOP: Results from a prospective cohort study
Hyun Ae Jung, Silvia Park, Jin Hyun Cho, Seonwoo Kim, Young Hyeh Ko, Seok Jin Kim, Won Seog Kim
Study on effectiveness of gemcitabine, dexamethasone, and cisplatin (GDP) for relapsed or refractory AIDS-related non-Hodgkin's lymphoma
Dong Ta Zhong, Chun Mei Shi, Qiang Chen, Jing Ze Huang, Jian Gang Liang
Current treatment of mantle cell lymphoma: results of a national survey and consensus meeting
M. Witzens-Harig, G. Hess, J. Atta, M. Zaiss, G. Lenz, C. Scholz, R. Repp, M. Reiser, C. Pott, H. Pelz, P. La Rosée, H. Kirchner, P. Kiewe, U. Keller, C. Buske, A. Viardot, M. Dreyling
Low incidence of thromboembolism in relapsed/refractory myeloma patients treated with thalidomide without thromboprophylaxis in Taiwan
Shang-Yin Wu, Yu-Min Yeh, Ya-Ping Chen, Wu-Chou Su, Tsai-Yun Chen
(Bortezomib plus lenalidomide/thalidomide)- vs (bortezomib or lenalidomide/thalidomide)-containing regimens as induction therapy in newly diagnosed multiple myeloma: a meta-analysis of randomized controlled trials
Anyou Wang, Qiaohong Duan, Xin Liu, Kaiyang Ding, Yongsheng Han, Weibo Zhu, Xiaoyan Cai, Jingsheng Wu, Zimin Sun
Radiotherapy for solitary plasmacytoma of bone and soft tissue
Yang-Gun Suh, Chang-Ok Suh, Jin Seok Kim, Soo-Jeong Kim, Hae Ok Pyun, Jaeho Cho
The use of adjusted ideal body weight for overweight patients undergoing HPC mobilisation for autologous transplantation
C. Hicks, A. Trickett, Y. L. Kwan, S. Ramanathan
Phytohemagglutinin-activated human T cells induce lethal graft-versus-host disease in cyclophosphamide and anti-CD122 conditioned NOD/SCID mice
Yongxian Hu, Yanjun Gu, Qu Cui, Huarui Fu, Lixia Sheng, Kangni Wu, Lizhen Liu, Shan Fu, Xiaohong Yu, He Huang
ABL1 deletion without BCR/ABL1 rearrangement is originated from a large-sized 9q deletion
Jungwon Huh, Yeung Chul Mun, Chu Myong Seong, Wha Soon Chung
Primary mucosa-associated lymphoid tissue (MALT) lymphoma of the liver: clinical, molecular, and microbiological aspects
Barbara Kiesewetter, Leonhard Müllauer, Berthold Streubel, Hermine Agis, Alexander Hirschl, Athanasios Makristathis, Markus Raderer
Usefulness of double-balloon enteroscopy for evaluation of duodenal follicular lymphoma
Sho Hangai, Fumihiko Nakamura, Atsuo Yamada, Hirotsugu Watabe, Motoshi Ichikawa, Kazuhiko Koike, Mineo Kurokawa
Primary intraocular lymphoma in a patient with systemic lupus erythematosus
Feng Jung S. H. Woei-A-Jin, Sabina Kersting, Jan Geert Bollemeijer
Fasting glucose level reduction induced by imatinib in chronic myeloproliferative disease with TEL-PDGFRβ rearrangement and type 1 diabetes
Adriano Salaroli, Giuseppina Loglisci, Alessandra Serrao, Giuliana Alimena, Massimo Breccia
Philadelphia-negative acute promyelocytic leukemia in a patient with chronic myeloid leukemia in complete cytogenetic response after treatment with tyrosine kinase inhibitor
Kyoko Inokura, Yasushi Onishi, Kenji Shimosegawa, Yoko Okitsu, Yuna Katsuoka, Tohru Fujiwara, Noriko Fukuhara, Kenichi Ishizawa, Hideo Harigae
Visceral leishmaniasis infection in a refractory multiple myeloma patient treated with bortezomib
Eugenio Piro, Mariagrazia Kropp, Renato Cantaffa, Angelo Giuseppe Lamberti, Guido Carillio, Stefano Molica
A novel frameshift mutation Gly239Serfs*8 in the PROC gene results in protein C deficiency in a Korean patient
Sang Hyuk Park, Seongsoo Jang, Hye-Kyung Yang, Hyoeun Shim, Chan-Jeoung Park, Hyun-Sook Chi, Yeon-Mok Oh
Deep vein thrombosis associated with factor V inhibitor followed by immune thrombocytopenia
Takakazu Higuchi, Takeshi Okamoto, Toshiyuki Kou, Tadashi Takeuchi, Ryosuke Koyamada, Sadamu Okada